Get the latest Science News and Discoveries

Subcutaneous semaglutide vs. placebo as adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity

None

Related news:

A new study finds that 35% of people who took an obesity drug called Semaglutide lost more than 20% of their total body weight, after 68 weekly injections. About 75% lost more than 10% of their body weight. The average weight loss was 15.3 kg.

« Efficient, systematic genetic analysis helps dissect disease inheritance

Characteristics, outcomes of US children, adolescents with multisystem inflammatory syndrome in children compared with severe COVID-19 »